Literature DB >> 4202704

Development and evaluation of a direct fluorescent antibody method for the diagnosis of Pneumocystis carinii infections in experimental animals.

S K Lim, W C Eveland, R J Porter.   

Abstract

Because no fully satisfactory diagnostic method has been available for use in pneumocystis infection, an attempt was made to apply the fluorescent antibody technique in the identification of Pneumocystis carinii. Hyperimmune sera were prepared in rabbits against P. carinii from human and rat sources. After proper adsorption, these antisera were conjugated with fluorescein isothiocyanate and used as reagents in a direct fluorescent antibody procedure. Each of the two reagents was found to stain trypsin-treated P. carinii organisms from either human or rat sources, indicating the presence of common antigens. Stained organisms were demonstrated in the hypopharyngeal material from rats in which pneumocystis infection had been activated by the administration of corticosteroid. From the results reported here, the procedure outlined is considered sufficiently sensitive and specific to justify tests on pneumocystis infections in man. The findings in a series of specimens from human subjects will be reported separately. The method also provides an extended approach to related research problems. The need for controls of the procedure at all points is emphasized.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4202704      PMCID: PMC379881          DOI: 10.1128/am.26.5.666-671.1973

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  12 in total

1.  Superiority of fluorescein isothiocyanate (Riggs) for fluorescent-antibody technic with a modification of its application.

Authors:  J D MARSHALL; W C EVELAND; C W SMITH
Journal:  Proc Soc Exp Biol Med       Date:  1958 Aug-Sep

2.  A simple fractionation method for preparation of fluorescein-labeled gamma globulin.

Authors:  J L RIGGS; P C LOH; W C EVELAND
Journal:  Proc Soc Exp Biol Med       Date:  1960-12

3.  Rapid fluorescein and protein assay method for fluorescent-antibody conjugates.

Authors:  A F Wells; C E Miller; M K Nadel
Journal:  Appl Microbiol       Date:  1966-03

4.  Immunohistochemistry in studies on the pathogenesis of Pneumocystis pneumonia in infants.

Authors:  W J Brzosko; K Madaliński; K Krawczyński; A Nowoslawski
Journal:  Ann N Y Acad Sci       Date:  1971-06-21       Impact factor: 5.691

5.  Pneumocystis carinii pneumonitis.

Authors:  M Bradshaw; R L Myerowitz; R Schneerson; J K Whisnant; J B Robbins
Journal:  Ann Intern Med       Date:  1970-11       Impact factor: 25.391

6.  Latent Pneumocystis infection of rats, relapse, and chemotherapy.

Authors:  J K Frenkel; J T Good; J A Shultz
Journal:  Lab Invest       Date:  1966-10       Impact factor: 5.662

Review 7.  Pneumocystis carinii pneumonitis. A review.

Authors:  J B Robbins
Journal:  Pediatr Res       Date:  1967-03       Impact factor: 3.756

8.  Fluorescent antibody studies on experimental pneumocytosis.

Authors:  S K Lim; R H Jones; W C Eveland
Journal:  Proc Soc Exp Biol Med       Date:  1971-02

9.  Diagnosis of Pneumocystis carinii pneumonitis by means of endobronchial brush biopsy.

Authors:  L H Repsher; G Schröter; W S Hammond
Journal:  N Engl J Med       Date:  1972-08-17       Impact factor: 91.245

10.  Studies of morphology and immunofluorescence of Pneumocystis carinii.

Authors:  H K Kim; W T Hughes; S Feldman
Journal:  Proc Soc Exp Biol Med       Date:  1972-10
View more
  15 in total

1.  Techniques for examining Pneumocystis carinii in fresh specimens.

Authors:  J J Ruffolo; M T Cushion; P D Walzer
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

Review 2.  Pneumocystis carinii pneumonia.

Authors:  J T Macfarlane; R G Finch
Journal:  Thorax       Date:  1985-08       Impact factor: 9.139

3.  Fractionation of Pneumocystis carinii developmental stages by counterflow centrifugal elutriation and sequential filtrations.

Authors:  J A De Stefano; J M Foy; D W Sullivan; S M Dawes; M T Cushion; G F Babcock; R G Sleight; H van Halbeek; P D Walzer
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

4.  Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia.

Authors:  P D Walzer; R D Powell; K Yoneda; M E Rutledge; J E Milder
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

5.  Dectin immunoadhesins and pneumocystis pneumonia.

Authors:  David M Ricks; Kong Chen; Mingquan Zheng; Chad Steele; Jay K Kolls
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

6.  Pneumocystis carinii pneumonia: detection of parasites in sputum and bronchoalveolar lavage fluid by monoclonal antibodies.

Authors:  K M Elvin; A Björkman; E Linder; N Heurlin; A Hjerpe
Journal:  BMJ       Date:  1988-08-06

7.  Experimental Pneumocystis carinii pneumonia in different strains of cortisonized mice.

Authors:  P D Walzer; R D Powell; K Yoneda
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

8.  Serum antibody responses to Pneumocystis carinii among different strains of normal and athymic mice.

Authors:  P D Walzer; M E Rutledge
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

9.  Direct fluorescent-antibody method for the diagnosis of Pneumocystis carinii pneumonitis from sputa or tracheal aspirates from humans.

Authors:  S K Lim; W C Eveland; R J Porter
Journal:  Appl Microbiol       Date:  1974-01

10.  Growth and serial passage of Pneumocystis carinii in the A549 cell line.

Authors:  M T Cushion; P D Walzer
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.